Clinical Trials on Type 1 Diabetes in Germany

Total 4493 results

Kinderkrankenhaus auf der Bult

Completed

Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D) (DREAM5)

Type 1 Diabetes

Germany
Insuline Medical Ltd.

Completed

Testing the Effect of the InsuPad Device in Daily Life Conditions

Diabetes Mellitus Type 2 | Diabetics Mellitus Type 1

Germany
Profil Institut für Stoffwechselforschung GmbH
European Union

Completed

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages

Diabetes Mellitus Type 1

Germany
Forschungsinstitut der Diabetes Akademie Mergentheim

Completed

Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

Germany
Technical University of Munich
Ludwig-Maximilians - University of Munich; Technische Universität Dresden; Helmholtz...

Active, not recruiting

Fr1da Insulin Intervention

Stage 1 Diabetes Mellitus, Type 1

Germany
Rabin Medical Center

Completed

Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home

Type 1 Diabetes

Israel, Germany, Slovenia
Adocia

Completed

A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Sanofi

Completed

Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Sanofi

Completed

Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1

Type 1 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1

Diabetes Mellitus

Germany
University of Giessen

Completed

Mechanisms of Glucose Counterregulation in Pancreatic Islet Transplantation

Type 1 Diabetes Mellitus

Germany
Rabin Medical Center
GIF

Withdrawn

Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes

Type 1 Diabetes

Germany, Israel
Kinderkrankenhaus auf der Bult

Completed

Comparison of Two Management Systems in Patients With Type 1 Diabetes (Pediatric SmartHome)

Drug Therapy | Patient Care

Germany
Adocia
Eli Lilly and Company

Completed

To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
National Institute of Diabetes and Digestive and...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"

Impaired Glucose Tolerance | High Risk | Autoantibody Positive | Non-diabetic Relatives at Risk for Type 1 Diabetes

United States, Canada, Germany
Sciema UG
Sanmina

Completed

Measurement Algorithm Control and Optimization With Subsequent Performance Evaluation of Sanmina Non-invasive Biosensors During a Standardized Meal Test in Patients With Diabetes Mellitus Type 1 and Type 2

Diabetes Mellitus

Germany
Diabeteszentrum Bad Lauterberg im Harz

Unknown

Comparison of Two Protocols on the Implementation of a Fasting Day in Type 1 Diabetes

Fasting

Germany
University of Cambridge
Medical University of Graz; Profil Institut für Stoffwechselforschung GmbH

Completed

Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions (AP@home04)

Type 1 Diabetes

United Kingdom, Austria, Germany
Adocia

Completed

A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM

Type 1 Diabetes Mellitus

Germany
Novartis Pharmaceuticals

Withdrawn

ACZ885 in Type 1 Diabetes Mellitus

Diabetes Mellitus | Diabetes Type 1

Germany, United Kingdom, United States, Canada
Diabeteszentrum Bad Lauterberg im Harz

Completed

Late Night Snack and Insulin Glargine

Hypoglycemia | Type 1 Diabetes

Germany
Eli Lilly and Company

Recruiting

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Healthy | Type 1 Diabetes Mellitus

Germany
Kinderkrankenhaus auf der Bult

Completed

Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update (UNIQUE)

Type 1 Diabetes | Insulin Therapy

Germany
University of Cambridge
Medical University of Graz; Cambridge University Hospitals NHS Foundation Trust and other collaborators

Completed

Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes (AP@home02)

Type 1 Diabetes

United Kingdom, Germany, Austria
National Institute of Diabetes and Digestive and...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Active, not recruiting

TEDDY - The Environmental Determinants of Diabetes in the Young

Type 1 Diabetes Mellitus

United States, Finland, Germany, Sweden
Dompé Farmaceutici S.p.A

Terminated

A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

New-onset Type 1 Diabetes

United States, Belgium, Georgia, Germany, Italy, Serbia
Sana Klinikum Offenbach
Wuerzburg University Hospital; Kuwait University; Cleveland Clinic Florida; SRH...

Completed

Long-term Results After Bariatric Surgery in Type 1 Diabetes Patients

Bariatric Surgery Status in T1D

Germany
Diabeteszentrum Bad Lauterberg im Harz
Berlin-Chemie Menarini

Completed

Glycemic Rises After Waking Up In Response To An Alarm Clock In Type 1-Diabetic Patients Analysed With Continuous Glucose Monitoring (GlucoDay®)

Stress | Type 1 Diabetes

Germany
Imcyse SA

Completed

Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes

Type 1 Diabetes Mellitus

United Kingdom, Belgium, Denmark, Germany, Lithuania, Sweden, France
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Canada, Germany
Novartis Pharmaceuticals

Completed

Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects (CCFZ533X2207)

Type 1 Diabetes Mellitus

Belgium, Italy, Spain, United Kingdom, Germany, Slovenia
Zealand Pharma

Completed

ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon

Diabetes Mellitus Type 1

Germany
Abbott Diabetes Care

Completed

An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT) (IMPACT)

Type 1 Diabetes Mellitus

Austria, Netherlands, Germany, Spain, Sweden
GlaxoSmithKline

Terminated

Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

France, Germany
Rabin Medical Center

Completed

Overnight MD-Logic

Type 1 Diabetes

Germany, Israel, Slovenia
Eli Lilly and Company

Completed

A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Maartje de Wit
King's College London; Juvenile Diabetes Research Foundation; University of Malaga and other collaborators

Recruiting

MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY) (MyREMEDY)

Type 1 Diabetes | Diabetes Distress

United Kingdom, Netherlands, Germany, Spain
Hoffmann-La Roche
Roche Diabetes Care GmbH

Completed

Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes (Insight Kids)

Diabetes Mellitus Type 1

Germany, Austria, United Kingdom
Profil Institut für Stoffwechselforschung GmbH
Pfizer

Terminated

DIATOR-Diabetes Intervention With Atorvastatin

Type 1 Diabetes

Germany
Spiden AG
Profil Institut für Stoffwechselforschung GmbH

Recruiting

Spiden Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

Type 1 Diabetes | Type2diabetes

Germany
University of Cambridge
Juvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaborators

Unknown

An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA) (INNODIA)

Type 1 Diabetes Mellitus

Austria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
Novo Nordisk A/S

Completed

First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Novo Nordisk A/S

Completed

Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Medtronic Diabetes

Completed

ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes (ADAPT)

Type 1 Diabetes

France, United Kingdom, Germany
Novo Nordisk A/S

Completed

A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes

Healthy | Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Mannkind Corporation

Completed

Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Novo Nordisk A/S

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Dompé Farmaceutici S.p.A

Active, not recruiting

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

New-onset type1 Diabetes

United States, Belgium, Georgia, Germany, Italy, Serbia, Israel, Slovenia
Becton, Dickinson and Company

Completed

Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Germany

Clinical Trials on Type 1 Diabetes in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations